alt
$12.20
+$0.19 (+1.6%)
Closing price October 18, 2021
24/7 Wall St. takes a look at famed market personality Jim Cramer’s latest buy and sell recommendations and overall analysis.
3 months ago
Wednesday's top analyst upgrades and downgrades included Alphabet, Canopy Growth, Cinemark, Dick's Sporting Goods, Facebook, IMAX, Microsoft, Salesforce.com and SBA Communications.
4 months ago
Last Updated: 1 month ago
Altimmune has announced additional preclinical data in regards to its single-dose intranasal COVID-19 vaccine candidate, AdCOVID.
7 months ago
Thursday's top analyst upgrades and downgrades included Allstate, Bed Bath & Beyond, Simon Property, Spirit Airlines, Twitter and Under Armour.
8 months ago
Last Updated: 8 months ago
Altimmune shares dropped on Thursday after the company announced that it had received an update from the FDA regarding its COVID-19 vaccine candidate.
9 months ago
Last Updated: 9 months ago
Altimmune made a step forward on Tuesday with its vaccine candidate for COVID-19. Specifically, the firm entered into a manufacturing agreement the vaccine candidate.
11 months ago
Last Updated: 9 months ago
Altimmune made some progress with its COVID-19 treatment on Monday after it announced some new funding for its trials.
1 year ago
Last Updated: 9 months ago
24/7 Wall St. has tracked some stocks that either are defensive in general or are defying Monday's big drop because they have some aspect of their business that might be immune to daily scares or...
1 year ago
Altimmune shares surged on Tuesday following results from its midstage study of a intranasal influenza vaccine candidate.
2 years ago
Last Updated: 9 months ago